m+Medelevator.RU
← Поиск публикаций
Gut · 2025

Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Trebicka Jonel, Aguilar Ferran, Queiroz Farias Alberto, Lozano Juan-José, Sánchez-Garrido Cristina, Usón-Raposo Eva, de la Peña-Ramirez Carlos, Sidorova Julia, Curto-Vilalta Anna, Sierra-Casas Patricia, Momoyo Zitelli Patricia, Papp Maria, Pereira Gustavo, Caraceni Paolo, Goncalves Luciana L, Alessandria Carlo, Torre Aldo, Laleman Wim, Gadano Adrián, Piano Salvatore, Mattos Angelo Z, Gu Wenyi, Brol Maximilian Joseph, Schierwagen Robert, Uschner Frank Erhard, Fischer Julia, Mendes Liliana S C, Vargas Victor, Alvares-da-Silva Mario R, Mookerjee Raj, Bittencourt Paolo L, Benitez Carlos, Albillos Agustín, Couto Cláudia, Mendizabal Manuel, Bañares Rafael, Toledo Claudio L, Mazo Daniel F, Janicko Martin, Castillo-Barradas Mauricio, Padilla Machaca Pedro Martin, Gatti Pietro, Miranda Adelina Zarela-Lozano, Malé-Velázquez René, Zipprich Alexander, Castro-Lyra André, Gustot Thierry, Bernal William, Gerbes Alexander L, Jalan Rajiv, Fernández Javier, Angeli Paolo, Carrilho Flair Jose, Claria Joan, Moreau Richard, Arroyo Vicente, PREDICT study and ACLARA study

Аннотация

BACKGROUND AND AIMS: Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance because SI is a driver of the most severe forms of ADC, including acute-on-chronic liver failure (ACLF). Blood biomarkers of SI already evaluated in ADC failed to appropriately assess SI in ADC. We aimed to investigate whether gene expression related to circulating immune cells could quantify SI in ADC.

METHODS: Standard biomarkers (white cell count, C reactive protein, cytokines) and genome-wide RNA expression (RNA-sequencing) were obtained in blood from 700 patients with ADC at the time of their hospital admission. A composite score based on standard biomarkers of SI (Chronic Liver Failure-Standard Biomarkers Composite (CLIF-SBC) score) and a gene score (CLIF-Systemic Inflammation Gene (SIG) score) composed of the 28 top differentially expressed immune cell-related genes in the comparison between high-severity and low-severity clinical phenotypes were computed. Among the 700 patients, the CLIF-SIG score was repeated once during follow-up in 375 patients, and 3 times or more in 46 patients.

RESULTS: The CLIF-SIG score was more accurate in reflecting clinical severity induced by SI than the CLIF-SBC score (area under the curve 0.803 vs 0.658). A CLIF-SIG score of 0.386 (Youden Index) was the best cut-off level discriminating patients with poor outcomes from the others, in all clinical scenarios. Sequential measurement of the CLIF-SIG score showed that 78% of patients were admitted at the peak or descending part of the SI-wave. ACLF developed during hospitalisation in 80% of patients with a CLIF-SIG score >0.386 on admission.

CONCLUSIONS: In patients with ADC, the CLIF-SIG score is an accurate estimator of SI, clinical course severity and prognosis.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты